165 related articles for article (PubMed ID: 34394283)
1. Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute.
Okello CD; Mulumba Y; Omoding A; Ddungu H; Welch K; Thompson CL; Cowan AJ; Cooney MM; Orem J
Afr Health Sci; 2021 Mar; 21(1):67-74. PubMed ID: 34394283
[TBL] [Abstract][Full Text] [Related]
2. The Role of
Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
4. Staging and survival in multiple myeloma.
Wahlin A
Scand J Haematol; 1984 Jul; 33(1):22-6. PubMed ID: 6463584
[TBL] [Abstract][Full Text] [Related]
5. Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma.
Spasov E; Goranova V
Folia Med (Plovdiv); 1998; 40(3B Suppl 3):121-3. PubMed ID: 10206011
[TBL] [Abstract][Full Text] [Related]
6. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases.
Qian J; Jin J; Luo H; Jin C; Wang L; Qian W; Meng H
Hematology; 2017 Sep; 22(8):472-476. PubMed ID: 28463078
[TBL] [Abstract][Full Text] [Related]
9. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
[TBL] [Abstract][Full Text] [Related]
11. One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute.
Natukunda B; Omoding A; Bongomin F; Mubiru KR; Ddungu H; Sekaggya-Wiltshire C; Mayanja-Kizza H
JCO Glob Oncol; 2023 Jul; 9():e2200244. PubMed ID: 37499182
[TBL] [Abstract][Full Text] [Related]
12. Analysis of criteria in staging in multiple myeloma.
Pennec Y; Mottier D; Youinou P; Asselain B; Miossec P; Le Goff P; Le Prise PY; Le Menn G
Haematologia (Budap); 1982; 15(2):221-6. PubMed ID: 7160667
[TBL] [Abstract][Full Text] [Related]
13. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and survival of Chilean patients with multiple myeloma].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
[TBL] [Abstract][Full Text] [Related]
15. Critical study of staging in multiple myeloma.
Pennec Y; Mottier D; Youinou P; Asselain B; Chavance M; Le Goff P; Le Prise PY; Miossec P; Le Menn G
Scand J Haematol; 1983 Feb; 30(2):183-90. PubMed ID: 6860419
[TBL] [Abstract][Full Text] [Related]
16. Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution.
Matuschek C; Ochtrop TA; Bölke E; Ganswindt U; Fenk R; Gripp S; Kröpil P; Gerber PA; Kammers K; Hamilton J; Orth K; Budach W
Radiat Oncol; 2015 Mar; 10():71. PubMed ID: 25889851
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
[TBL] [Abstract][Full Text] [Related]
18. Association Between HIV Infection and Cancer Stage at Presentation at the Uganda Cancer Institute.
Menon MP; Coghill A; Mutyaba IO; Phipps WT; Okuku FM; Harlan JM; Orem J; Casper C
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241147
[TBL] [Abstract][Full Text] [Related]
19. Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989.
Schaapveld M; Visser O; Siesling S; Schaar CG; Zweegman S; Vellenga E
Eur J Cancer; 2010 Jan; 46(1):160-9. PubMed ID: 19682891
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
